Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-04-04 00:00:00 ET · period of report 2023-04-03 · accession 0001209191-23-023062 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-04-03 | BMRN | LAWLIS V BRYAN | Dir | M - OptEx | $67.81 | +8,500 | 37.5K | +29% | +$576.4K |
| D | 2023-04-04 | 2023-04-03 | BMRN | LAWLIS V BRYAN | Dir | S - Sale+OE | $97.09 | -8,500 | 28.9K | -23% | -$825.3K |
| D | 2023-04-04 | 2023-04-03 | BMRN | LAWLIS V BRYAN | Dir | M - OptEx | $0.00 | -8,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-03 | M | A | 8,500 | $67.81 | 37,450 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on August 29, 2022. |
| 2 | Common | Common Stock | 2023-04-03 | S | D | 8,500 | $97.09 | 28,950 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on August 29, 2022. |
| 3 | Derivative | Stock Option (Right to Buy Common Stock) | 2023-04-03 | M | D | 8,500 | $0.00 | 0 | D | $67.81 · 2013-11-15 to 2023-05-14 | 8,500 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on August 29, 2022. (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |